Live courses

Title Credit Cost Dates
NCCN Pharmacy Updates: The Role of Tyrosine Kinase Inhibitors in Pediatric Acute Lymphoblastic Leukemia
    • 1.00 ANCC contact hours
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ACPE contact hours
    • 1.00 AAPA Category 1 CME credit
    • 1.00 Participation
 $0.00 08/24/2022 - 1:30pm to 2:30pm EDT
Monthly Oncology Tumor Boards: Updates in the Treatment of Nasopharyngeal Carcinoma
    • 1.00 CCM clock hours
    • 1.00 ANCC contact hours
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ACPE contact hours
    • 1.00 AAPA Category 1 CME credit
    • 1.00 Participation
 $0.00 08/29/2022 - 1:00pm to 2:00pm EDT
Monthly Oncology Tumor Boards: Treatment of Patients with Bladder and Upper Tract Urothelial Cancer
    • 1.00 CCM clock hours
    • 1.00 ANCC contact hours
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ACPE contact hours
    • 1.00 AAPA Category 1 CME credit
    • 1.00 Participation
 $0.00 09/29/2022 - 11:30am to 12:30pm EDT
NCCN Pharmacy Updates: Updates in the Management of Indolent Non-Hodgkin Lymphomas
    • 1.00 ANCC contact hours
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ACPE contact hours
    • 1.00 AAPA Category 1 CME credit
    • 1.00 Participation
 $0.00 10/07/2022 - 11:30am to 12:30pm EDT
Monthly Oncology Tumor Boards: Treatment of Patients with Kidney Cancer
    • 1.00 CCM clock hours
    • 1.00 ANCC contact hours
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ACPE contact hours
    • 1.00 AAPA Category 1 CME credit
    • 1.00 Participation
 $0.00 10/25/2022 - 12:00pm to 1:00pm EDT

Pages

Featured Online Courses

Title Credit Type Event date Cost
Acute Myeloid Leukemia: Evidence-Based Guidance on Current Paradigms and New Therapeutic Approaches
    • 2.50 AAPA Category 1 CME credit
    • 2.50 ACPE contact hours
    • 2.50 AMA PRA Category 1 Credit™
    • 2.50 ANCC contact hours
    • 2.50 Participation
 Enduring $0.00
Applying Guideline Updates and Real-World Experience in CLL: Experts Review State-of-the-Art Evidence and Address Clinical Challenges
    • 2.50 AAPA Category 1 CME credit
    • 2.50 ACPE contact hours
    • 2.50 AMA PRA Category 1 Credit™
    • 2.50 ANCC contact hours
    • 2.50 Participation
 Enduring $0.00
Application of Individualized Treatment Strategies for CLL/SLL
    • 2.00 ANCC contact hours
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 ACPE contact hours
    • 2.00 AAPA Category 1 CME credit
    • 2.00 Participation
 Enduring $0.00
Current and Emerging Systemic Therapies for Hepatocellular Carcinoma: Clinical Evidence and Guideline Recommendations
    • 1.50 AAPA Category 1 CME credit
    • 1.50 ACPE contact hours
    • 1.50 AMA PRA Category 1 Credit™
    • 1.50 ANCC contact hours
    • 1.50 Participation
 Enduring $0.00
Clinical Considerations in Renal Cell Carcinoma: Current Evidence, Guideline Recommendations, and a View to the Future
    • 2.00 ANCC contact hours
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 ACPE contact hours
    • 2.00 AAPA Category 1 CME credit
    • 2.00 Participation
 Enduring $0.00

Transcript

Please login or create an account to view your activities.

Pending Activities

Please login or create an account to view your activities.